about
The tetraspanin protein CD37 regulates IgA responses and anti-fungal immunityLung parenchyma-derived IL-6 promotes IL-17A-dependent acute lung injury after allogeneic stem cell transplantationAn activated Th17-prone T cell subset involved in chronic graft-versus-host disease sensitive to pharmacological inhibition.The tetraspanin CD37 orchestrates the α(4)β(1) integrin-Akt signaling axis and supports long-lived plasma cell survival.Tetraspanins CD37 and CD151 differentially regulate Ag presentation and T-cell co-stimulation by DC.Donor colonic CD103+ dendritic cells determine the severity of acute graft-versus-host disease.The Carbomer-Lecithin Adjuvant Adjuplex Has Potent Immunoactivating Properties and Elicits Protective Adaptive Immunity against Influenza Virus Challenge in Mice.Acute graft-versus-host disease is regulated by an IL-17-sensitive microbiome.Polyethyleneimine is a potent mucosal adjuvant for viral glycoprotein antigens.Polyethyleneimine is a potent systemic adjuvant for glycoprotein antigens.Sterile inflammation induced by Carbopol elicits robust adaptive immune responses in the absence of pathogen-associated molecular patterns.Characterising the effect of antimalarial drugs on the maturation and clearance of murine blood-stage Plasmodium parasites in vivo.Eomesodermin promotes the development of type 1 regulatory T (TR1) cells.Differential production of inflammatory chemokines by murine dendritic cell subsets.Tc17 cells are a proinflammatory, plastic lineage of pathogenic CD8+ T cells that induce GVHD without antileukemic effects.Tetraspanin CD37 contributes to the initiation of cellular immunity by promoting dendritic cell migration.Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: a phase 1/2 trial.A critical role for donor-derived IL-22 in cutaneous chronic GVHD.Development of a Multiplexed Microsphere PCR for Culture-Free Detection and Gram-Typing of Bacteria in Human Blood Samples.Flt-3L expansion of recipient CD8α+ dendritic cells deletes alloreactive donor T cells and represents an alternative to post-transplant cyclophosphamide for the prevention of GVHD.Granulocytes Are Unresponsive to IL-6 Due to an Absence of gp130.Reactive carbonyls are a major Th2-inducing damage-associated molecular pattern generated by oxidative stress.Imaging the immunological synapse between dendritic cells and T cells.Recipient mucosal-associated invariant T cells control GVHD within the colon.Th17 plasticity and transition toward a pathogenic cytokine signature are regulated by cyclosporine after allogeneic SCTCross-Dressing by Donor Dendritic Cells after Allogeneic Bone Marrow Transplantation Contributes to Formation of the Immunological Synapse and Maximizes Responses to Indirectly Presented AntigenBone marrow transplantation generates T cell-dependent control of myeloma in micePerforin inhibition protects from lethal endothelial damage during fulminant viral hepatitisExpansion of IL-17A-secreting CD8 mucosa-associated invariant T cells in peripheral blood following stem cell mobilizationConventional dendritic cells are required for the cross-presentation of leukemia-specific antigen in a model of AML relapse post-BMTDonor T-cell-derived GM-CSF drives alloantigen presentation by dendritic cells in the gastrointestinal tractMyeloma escape after stem cell transplantation is a consequence of T-cell exhaustion and is prevented by TIGIT blockadePhase I Trial of Inducible Caspase 9 T Cells in Adult Stem Cell Transplant Demonstrates Massive Clonotypic Proliferative Potential and Long-term Persistence of Transgenic T CellsImaging Flow Cytometry to Assess Antigen-Presenting-Cell Function
P50
Q33417649-7CBC35F1-C1D0-4E33-85DF-E6F2517F18FBQ33758318-F7C883E6-D6E9-4AEC-94CF-2CB3D4A5B71EQ33798102-5FAB60B0-CB02-4E93-9EDA-BD1FF269F00FQ34311595-553074DE-9A09-45C9-B40A-F9544B974952Q34906225-B68AEE9D-1A60-4E57-BAA0-27A38D77CAF3Q35894369-AEF80EFC-CA7A-4BDE-B8C2-C6BC12F72639Q35998757-7EACB208-A107-4422-90E5-F95442883286Q36264301-AF0790E3-69DE-499A-B88B-E9A94E7092A1Q36395541-B2F5DDC7-DDE4-4624-865B-9062033971D6Q38306977-F1743A98-AA09-4A3C-8E7C-DC151731A00EQ38783989-2281B301-6EA6-4AFA-9159-88B409A45E4DQ40070354-986C5410-2DE1-4F83-AD65-AEC30C93F5F2Q40110847-689B5DB3-A352-4B5A-837D-61F41CD56ECFQ42469057-A5AD7A2F-E7BA-4E80-B2AB-368CD90DC8F5Q43814840-B99C524E-3F37-4DE4-951F-742B6A354832Q44501041-5C24A4AE-6822-411C-9563-39A675553223Q45050218-6C4D6633-6B4A-4900-B9D5-7959090BC2EBQ47935463-62A6145B-0FA9-45C1-957B-04D66D8699F4Q48208664-02011823-17CC-436E-AAA9-D8074EF6E6AFQ48524416-B198327C-AE5F-41F7-BB72-81506444DE61Q52329540-FCB8BC1F-5310-4259-BB62-C00EFBBEBD8CQ53086511-9564AE4F-44E1-4A5B-B631-B7D39EA4CC15Q53509729-CB0E9EFB-E205-4A77-8062-FB03FE15266CQ54239585-7A3C9A37-FE90-4F44-84C7-6EC3444318A2Q57252613-92AD86B8-DA59-4E4A-8792-AF8B5E81A2A2Q57252616-46C35A2D-5BB0-4003-B70E-4C52BC0A846FQ57289945-9DED52CF-A8D1-41EB-BE91-95A51A9D1236Q59136675-0E8103C5-2301-4C78-A60C-3C98B6BB1AB3Q64093795-42AA2F47-4E62-40CE-BFDF-FF77CDE16D42Q88044738-D51A0BDA-9BF5-4CEE-BF64-7C132B1D559CQ90493849-81F9A47D-6B15-4098-A554-3237F18CD0E9Q91183008-6E58C1F1-6D77-4D95-8056-DE79887E1F01Q91593879-6EEB1794-921E-4EDC-B493-86DB453EF154Q92165437-B2ED3E6A-9E8A-4C4D-9F64-40D81124716F
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Kate H Gartlan
@ast
Kate H Gartlan
@en
Kate H Gartlan
@es
Kate H Gartlan
@nl
Kate H Gartlan
@sl
type
label
Kate H Gartlan
@ast
Kate H Gartlan
@en
Kate H Gartlan
@es
Kate H Gartlan
@nl
Kate H Gartlan
@sl
prefLabel
Kate H Gartlan
@ast
Kate H Gartlan
@en
Kate H Gartlan
@es
Kate H Gartlan
@nl
Kate H Gartlan
@sl
P1053
C-5315-2009
P106
P21
P31
P3829
P496
0000-0002-0343-1274